7. Watson Pharmaceuticals ( WPI) is an integrated global pharmaceutical company dealing in generic and brand pharmaceutical products. The company manages its business into three operating segments: Generics, Brands and Distribution. Watson will announce third-quarter results Nov. 1. Net income for the third quarter of 2011 is estimated at $132.54 million on sales of $1.09 billion, higher than net income of $105.80 million recorded on $882.4 million sales for the same period in 2010, as per analysts polled by Bloomberg. For the quarter, earnings per share are forecast at $1.05 cents, vs. 85 cents registered in 2010 third quarter. Meanwhile, a multifold increase in operating profit is likely at $223.45 million, rising from $34.50 million in the year-ago period. Of the 22 analysts covering the stock, 59% recommend a buy and the rest rate a hold. There are no sell ratings on the stock. Analysts polled by Bloomberg expect the stock to gain an average 12.1% to $78.00 from current levels over the next 12 months.